InsidersTradesSigma
Track the 멕아이씨에스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 멕아이씨에스 has published 58 insider filings. Market capitalisation: €24.3bn. The latest transaction was filed on 6 May 2026 (Other). Among the most active insiders: 김종철. Every trade is accessible without an account.
56
Insider Decl.
n/a
Thresholds
€19,322
35 ops.
Buy Volume
n/a
4 ops.
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,186 of 29,063 companies
28.2
score / 100
Value16
Quality40
FCF yld-9.9%
Earn yld-9.8%
EV/EBITDA·
ROE·
Gross mgn55%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 May 2026
Declarations58 total
Other
Other
25 of 58 declarations
Acerca de 멕아이씨에스
멕아이씨에스 es una empresa que opera en el sector de la salud y farmacéutico, cotizando en la XKRX. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.